SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-128461
Filing Date
2020-11-23
Accepted
2020-11-23 16:19:05
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029587-1_10q.htm 10-Q 568276
2 EXHIBIT 10.5 tm2029587d1_ex10-5.htm EX-10.5 232934
3 EXHIBIT 31.1 tm2029587d1_ex31-1.htm EX-31.1 8085
4 EXHIBIT 31.2 tm2029587d1_ex31-2.htm EX-31.2 8076
5 EXHIBIT 32.1 tm2029587d1_ex32-1.htm EX-32.1 3937
6 EXHIBIT 32.2 tm2029587d1_ex32-2.htm EX-32.2 3965
  Complete submission text file 0001104659-20-128461.txt   4977020

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ards-20200930.xml EX-101.INS 972209
8 XBRL TAXONOMY EXTENSION SCHEMA ards-20200930.xsd EX-101.SCH 54359
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ards-20200930_cal.xml EX-101.CAL 39596
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ards-20200930_def.xml EX-101.DEF 180213
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ards-20200930_lab.xml EX-101.LAB 453532
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ards-20200930_pre.xml EX-101.PRE 347415
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 201337563
SIC: 2834 Pharmaceutical Preparations